Elago, Scarlet Faith L.
HRN: 19-52-81 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2022
CEFUROXIME 750MG (VIAL)
09/29/2022
10/06/2022
IV
280mg
Q8
Mild Tbi Sec To Fall
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes